MTB
REGN icon

Mizuho Trust & Banking’s Regeneron Pharmaceuticals REGN Stock Holding History

Mizuho Trust & Banking’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-126,404
Closed -$50.8M – 524
2016
Q3 		$50.8M Buy
126,404
+4,221
+3% +$1.69M 0.15% 153
2016
Q2 		$42.7M Buy
122,183
+2,885
+2% +$1.11M 0.13% 172
2016
Q1 		$43M Buy
119,298
+4,731
+4% +$1.95M 0.14% 158
2015
Q4 		$62.8M Buy
114,567
+1,016
+0.9% +$550K 0.21% 111
2015
Q3 		$52.8M Buy
113,551
+5,293
+5% +$2.84M 0.18% 126
2015
Q2 		$55.2M Sell
108,258
-4,556
-4% -$2.22M 0.18% 128
2015
Q1 		$50.9M Buy
112,814
+6,975
+7% +$2.96M 0.17% 127
2014
Q4 		$43.4M Buy
105,839
+6,242
+6% +$2.45M 0.15% 144
2014
Q3 		$35.7M Sell
99,597
-4,528
-4% -$1.52M 0.14% 162
2014
Q2 		$29.4M Buy
104,125
+35
+0% +$10.4K 0.11% 222
2014
Q1 		$31.3M Sell
104,090
-2,371
-2% -$730K 0.12% 198
2013
Q4 		$30.2M Buy
106,461
+1,537
+1% +$442K 0.11% 206
2013
Q3 		$23.6M Hold
104,924
– – 0.1% 243
2013
Q2 		$23.6M Buy
+104,924
New +$24.4M 0.1% 241

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Mizuho Trust & Banking's REGN Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of Regeneron Pharmaceuticals (REGN) in Q4 2016, closing a stake of 126,404 shares — an estimated $50.8M sold.

Mizuho Trust & Banking first reported a position in REGN in Q2 2013 and held it in 14 quarters. The position peaked at $62.8M in Q4 2015. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2016.

  • Mizuho Trust & Banking reported no remaining Regeneron Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Mizuho Trust & Banking sold 126,404 Regeneron Pharmaceuticals shares in Q4 2016, an estimated $50.8M.
  • Mizuho Trust & Banking first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Mizuho Trust & Banking's Regeneron Pharmaceuticals position peaked at $62.8M in Q4 2015.
  • 576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.